Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+304.4%
5Y CAGR+153.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+304.4%/yr
Annual compound
5Y CAGR
+153.0%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
103.6x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4758.67 | +8423.2% |
| 2024 | 55.83 | -49.2% |
| 2023 | 109.91 | +52.7% |
| 2022 | 71.95 | +127.3% |
| 2021 | -263.60 | -673.9% |
| 2020 | 45.93 | - |